In November, the European Union Drugs Agency launched a comprehensive drug threat assessment system designed to bolster Europe’s preparedness against serious and emerging substance-related crises. The EUDA Health and Security Threat Assessment System, known as ETAS, marks a significant advancement in coordinating responses across member states to rapidly evolving drug markets and consumption patterns.

Unveiled at the Heads of Reitox national focal points meeting in Lisbon, the new drug threat assessment system provides structured, evidence-based evaluations to support timely decisions on mitigation, early preparedness and strategic responses at both national and EU levels.

Comprehensive Framework for Substance Crisis Response

ETAS operates as a core component of the EUDA’s wider preparedness framework. The drug threat assessment system works in close coordination with the European Drug Alert System, the EU Early Warning System on new psychoactive substances, and the Network of forensic and toxicological laboratories. Together, these services combine early warning, rapid alerts and in-depth assessments.

This integrated approach reinforces Europe’s capacity to detect and respond to fast-evolving substance-related risks. The system helps EU member states identify, assess and respond to health and security threats linked to drug markets, illicit substances and changing patterns of use.

Authorities can trigger threat assessments through requests from an EU member state or the European Commission. The system also activates when signals from the EUDA’s monitoring, alert and early warning systems indicate that a coordinated response may be needed. Member state requests are submitted via the EUDA Management Board member or through the national focal point.

Evidence-Based Action Through Strategic Assessment

The drug threat assessment system draws on data from multiple sources. Health authorities provide medical impact data. Law enforcement contributes market intelligence. Laboratory sources supply chemical analysis. Expert input from national authorities ensures comprehensive evaluation.

ETAS delivers practical options for action, tailored to different threats. This evidence-based approach enables member states and EU institutions to turn intelligence into concrete measures on the ground. The system contributes to a safer and more resilient Europe through coordinated, strategic responses.

National focal points act as key contact points for ETAS. They contribute throughout the assessment process, ensuring local knowledge informs European strategy. This partnership model strengthens the connection between EU-level coordination and member state implementation.

Addressing Synthetic Opioids and Crack Cocaine

The first assessments under the new system focus on two critical challenges. Highly potent synthetic opioids represent an immediate threat across Europe. The availability and harms of crack cocaine in the EU require urgent evaluation.

These assessments are being carried out in close cooperation with the countries concerned. The system’s flexibility allows tailored responses to specific regional challenges whilst maintaining coordinated European oversight.

A pilot threat assessment published in June 2025 examined the evolving presence and impact of highly potent synthetic opioids in the Baltic States. The assessment specifically addressed nitazenes and carfentanil, substances linked to severe overdose risks. These early cases illustrate how the drug threat assessment system supports member states in developing concrete preventive measures.

The synthetic opioid crisis particularly concerns health authorities. These substances often appear in illicit drug supplies without users’ knowledge. Their extreme potency creates unprecedented overdose risks. The drug threat assessment system enables rapid identification and coordinated response before regional problems become continental crises.

The Reitox Alliance: Strengthening European Cooperation

A central issue at November’s meeting involved the Reitox Alliance, a new partnership framework between the EUDA and national focal points. Building on decades of shared experience, the alliance aims to strengthen cooperation, enhance preparedness and ensure a coordinated European response to emerging substance-related challenges.

The new operating framework, set for adoption by the Management Board in December, will replace the previous Reitox operating framework functioning since 2003. The alliance aligns the network’s activities with the EUDA’s updated mandate. It promotes mutual support, capacity building and innovation among member states.

This partnership model ensures the drug threat assessment system operates within a robust cooperative structure. National expertise informs European strategy whilst EU resources support national implementation. The reciprocal relationship strengthens both local and continental responses.

Strategic Focus on Prevention and Preparedness

The November meeting also focused on policy and institutional updates, scientific projects, national reporting, communication activities and planning for 2026. Topics included cannabis policy, prisons and international cooperation. These discussions inform how the drug threat assessment system will address future challenges.

Cannabis policy developments across Europe require coordinated monitoring. Changing legal frameworks in some jurisdictions create cross-border complications. The system enables assessment of health and security impacts from these policy shifts.

Prison populations face particular vulnerability to substance-related harms. The drug threat assessment system can evaluate emerging threats within correctional settings. This includes new psychoactive substances entering prisons and changing consumption patterns among incarcerated populations.

International cooperation extends the system’s reach beyond EU borders. Drug markets operate globally. Effective threat assessment requires intelligence sharing with international partners. The framework facilitates this broader coordination.

Leadership Transition and Future Direction

The November meeting represented the last Reitox gathering under outgoing Executive Director Alexis Goosdeel, whose mandate ended on 31 December. Speaking at the event, Mr Goosdeel emphasised the significance of the new framework.

“The new Reitox Alliance will mark a significant step forward in how we work together as a European network,” Goosdeel stated. “It will give us a stronger, more coordinated platform for tackling the complex drug challenges we face.”

He highlighted how ETAS exemplifies the renewed partnership’s potential. “ETAS is just one example of how this enhanced cooperation can translate shared expertise into concrete, operational services that help member states anticipate threats and act quickly.”

Goosdeel expressed confidence in the system’s long-term impact. “As I conclude my mandate, I am proud of what we have achieved together and confident that this enhanced cooperation will support Europe’s preparedness for years to come.”

Building Resilient Communities Through Strategic Intelligence

The drug threat assessment system represents a fundamental shift in European substance policy. Rather than reactive crisis management, the framework enables proactive threat identification. Member states can implement preventive measures before emerging problems escalate into public health emergencies.

This approach particularly benefits communities. Early identification of synthetic opioids entering local markets enables targeted public health interventions. Rapid assessment of crack cocaine availability informs community safety strategies. The system translates continental intelligence into neighbourhood protection.

The framework also supports evidence-based policy development. Policymakers access comprehensive threat assessments when considering regulatory changes. This reduces the risk of unintended consequences from well-intentioned but poorly informed policy decisions.

Healthcare providers benefit from early warning of emerging substances. Treatment services can prepare for new clinical presentations. Harm reduction programmes can adjust their approaches based on current market realities. The drug threat assessment system ensures frontline services remain equipped for evolving challenges.

Law enforcement agencies gain strategic intelligence for operational planning. Understanding supply chain dynamics enables more effective interdiction. Recognising emerging drug markets allows proactive rather than reactive policing. The system supports smarter, more targeted enforcement strategies.

A Model for Global Substance Crisis Response

Europe’s new drug threat assessment system offers lessons for other regions. The integrated approach combining health, security and laboratory data provides comprehensive threat evaluation. The partnership model between EU agencies and national focal points ensures local knowledge informs continental strategy.

Other regions facing substance crises might adapt this framework. The principles of early identification, evidence-based assessment, and coordinated response apply universally. The specific mechanisms can be tailored to different governance structures and resource levels.

The system’s emphasis on prevention rather than merely managing existing crises represents a strategic evolution. Communities benefit most when authorities identify and address threats before they manifest as widespread harm. The drug threat assessment system prioritises this proactive approach.

As Europe implements ETAS, the international community will watch closely. The system’s effectiveness in addressing synthetic opioids and crack cocaine will demonstrate whether this model can genuinely strengthen preparedness. Early indicators suggest the framework provides the coordinated, evidence-based response that substance crises demand.

Source: EUDA